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Abstract
It is known that the proper function of the vacuolar H-ATPase is inhibited by bafilomycin A1. In transfected cells the E5
protein interacts with the 16 kDa subunit of the vacuolar H-ATPase. Thereby the pH gradient in endocytic structures is
impaired. The present study demonstrates for the first time that the inhibition of the vacuolar H-ATPase in NIH3T3 cells
with bafilomycin A1 or by transfection of cells with the HPV-16 E5 oncogene leads to a changed morphology and a reduced
motility as shown by computer-assisted video recordings and image analysis. Bafilomycin A1 potentiates the effect of the E5
protein on cell motility and this cooperative effect indicates that the E5 protein and bafilomycin A1 either target the vacuolar
H-ATPase differently or that the E5 protein has additional targets in transfected cells. Our data therefore show that proper
function of the vacuolar H-ATPase is needed for normal cell locomotion. ß 1999 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Immortalization and transformation of cells often
lead to changed cell morphology and motility [1^3]
due to changes in tumor cell adhesion to the extra-
cellular matrix and alterations in transmembrane and
intracellular signalling [4,5]. Changes in intracellular
pH are also observed in transformed cells [6]. This
may be mediated by Human Papillomaviruses (HPV)
which are small circular DNA viruses involved in
malignant transformation (for review see [7]). The
size of the HPV genome is eight kilobasepairs and
encodes at least eight proteins E1, E2, E4^E7, L1
and L2 of which E5, E6 and E7 are oncoproteins as
indicated by their interference with the cell growth
control. The HPV-16 E5 oncoprotein is a small, very
hydrophobic protein [8^10] which binds to the
16 kDa subunit of the vacuolar H-ATPase pump
[11,12] and thus interferes with the acidi¢cation of
endocytic structures [13,14]. The E5 protein also
stimulates the epidermal growth factor receptor
(EGFR) signalling [15,16], delays degradation of
the EGF receptor on the cell surface and blocks
cell-to-cell communication [17,18].
In the present study we analyze the in£uence of
impairment of the vacuolar H-ATPase on cell mor-
phology and cell locomotion by the use of cell lines
transfected with the E5 gene or exposed to ba¢lomy-
cin A1. Ba¢lomycin A1 is known to inhibit the vac-
uolar proton pump speci¢cally and to prevent acid-
i¢cation of endocytic structures [19].
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We demonstrate distinct changes in the morphol-
ogy and motility of E5 transfected cells by the use of
video recording, combined with computer-assisted
image analysis. Treatment of cells with ba¢lomycin
A1 also leads to reduction of cell motility and our
data indicate a cooperative e¡ect of the E5 protein
and the drug on cell motility. The observations show
for the ¢rst time that the function of the vacuolar
H-ATPase is important for maintenance of cell
morphology and cell locomotion.
2. Materials and methods
2.1. Cell cultures and transfection
NIH3T3 A31 mouse ¢broblasts (American Type
Culture Collection, ATCC no. CCL 163) from
Balb/c mouse embryo [20] were used for transfection
with the E5 gene (sequence 3841^4110 from HPV-16)
inserted into the pJ46 vector or with the vector
alone (the vector was generously donated by Profes-
sor H. Land, The Imperial Cancer Research Fund,
London, UK). The HPV-16 genome was a generous
gift of Dr. H. zur Hausen, Heidelberg, Germany).
Cells were grown in 6 cm tissue culture dishes
(NUNC, Denmark) for transfection. The pSV2Neo
expression vector was cotransfected with the E5 or
pJ46 DNA using lipofectin (GIBCO BRL Life-
tech #18292011). G418 (GIBCO BRL Lifetech
#066-01811) was used to select for transfected
cells. The cells were routinely grown in Dul-
becco’s modi¢ed Eagle’s medium (DMEM, Gibco
BRL) supplemented with 10% v/v heat-in-
activated fetal calf serum (FCS), penicillin (100 U/
ml), streptomycin (100 g/ml) and G418 (0.5 mg/ml).
Individual clones were isolated, expanded and were
passaged 5^10 times before assays were undertak-
en.
2.2. Treatment of cells with ba¢lomycin A1
Ba¢lomycin A1 (Sigma #8281) was dissolved in
DMSO. Cells were seeded and incubated for 24 h,
then treated for 3 h with ba¢lomycin A1 in the con-
centrations speci¢ed in the text or with DMSO alone
(0.05% v/v, controls) before analysis of cell motil-
ity.
2.3. RNA puri¢cation and reverse transcriptase PCR
Cells grown in a T80 £ask with 5^10U106 cells
were washed twice with PBS. One ml Ultraspec (Bio-
tecx Laboratories, Inc, #BL-10100) was added before
resuspension. The cell suspension was transferred to
an eppendorf tube and kept on ice for 5 min. 200 ml
chloroform (Merck) was added and the sample was
vortexed for 15 s followed by 5 min on ice. The two
phases were separated by centrifugation for 15 min
at 12 000Ug at 4‡C. The upper phase was transferred
to a new eppendorf tube and precipitated by 1Uvol-
ume isopropanol (Merck). The tube was cooled for
10 min on ice before centrifugation for 10 min at
12 000Ug at 4‡C. Pellet was washed twice with ice
cold 75% ethanol (Merck) and dried. Before the pel-
let was completely dry it was resuspended in 50^100
ml DEPC water (Biotecx, #BL-5610) followed by
vortexing for 1 min. The RNA concentration was
measured at 260 nm and 280 nm. The RNA prepa-
ration was considered pure if the OD260=280 ratio was
in the interval of 1.8^2.0. Reverse transcriptase PCR
was done according to the procedure from the Gene-
Amp RNA PCR kit from Perkin Elmer (N808-0017).
The primers used were 21 bp long and corresponding
to the N- and C-terminal sequence of the E5 gene [9].
The ampli¢ed c-DNA was analyzed on the 1.5%
agarose gel with HinfI digested pBR322 as size
marker.
2.4. Determination of cell motility
Motility of individual cells was evaluated as pre-
viously described [21]. The dishes were placed on a
thermostatically controlled stage mounted on a mi-
croscope. The modi¢ed Plexiglas incubator (Nikon,
Japan) was mounted around the microscopic stage.
The temperature inside the incubator was maintained
at 37‡C using a thermostatically controlled heating
fan (DFA, Denmark). Video recordings were made
with a black and white CCD video camera (Burle,
USA). Automated 512U512 pixel image acquisition
of 15^20 randomly chosen microscopic ¢elds from
each culture dish was performed using a Nikon
X,Y-movable stage mounted on the Nikon Diaphot
300 inverted microscope. Automated image acquisi-
tion and storage was performed at 15 min intervals
over a period of 5 h. Images were recorded from 10^
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15 di¡erent ¢elds/well using the software PRIMA
(Protein laboratory, Denmark). Before recording,
the lids on culture dishes were tightly sealed by
means of autoclave tape and placed on the micro-
scopic stage for approximately 30 min for equilibra-
tion. The position of the nucleolus in each cell was
marked and converted into nucleolus coordinates. In
order to exclude the in£uence of cell^cell interactions
on cellular motility and morphology, only single cells
were evaluated. Data were expressed as the mean-
square displacement of the cells, Gd2f in relation to
the time interval in min (d), and ¢tted to the equation
describing individual cell motility as a persistent ran-
dom walk [22,23]: Gd2f  2S2Pd3P13e3d=P,
where S is the root-means-square speed (distance/
time), and P is the persistence time in direction.
Also, the rate of di¡usion R (distance2/time) was
calculated, R being equal to 2S2P for dEP. When
¢tting experiment data to the theoretical curve, it
was of importance to the accuracy of the estimation
of P and S, that the observation time was consider-
ably longer than P, ensuring that the curve had
reached the linear part [21].
2.5. Determination of cell morphology
Video recording and determination of cell mor-
phology was performed as described previously
[24,25], using the same equipment as in the experi-
ments dealing with cell motility measurements. Cell
contours from the stored images of the live cells were
determined automatically by means of thresholding
and binary transformation using the image process-
ing software PRIMA (Protein Laboratory, Den-
mark). In order to exclude the in£uence of cell^cell
interaction on cell morphology, only single cells were
measured. Based on the delineated contour, cellular
area and form factor (4ZUarea/perimeter2) were
computed. For ba¢lomycin A1 treated cells, record-
ings were done after 3 h, 6 h, 8 h or 24 h of incuba-
tion with ba¢lomycin A1. Form factor varies from 1
(describing a circle) to 0. Values below 1 indicate an
elongated cell body and increasing number of cellular
processes.
2.6. Statistics
Statistics were evaluated by the use of Statsoft
Statistica version 4.5 (Statsoft, UK), Fig. P v2.2 (Bio-
soft, UK), PRIMA (Protein laboratory, Denmark).
Student’s t-test has been used for calculation of sig-
ni¢cant di¡erences of cell morphology and motility.
2.7. Measurement of intracellular pH in transfected
cells
Cells were seeded in 8 well chamber slides (Lab-
Tek, USA) with 104 cells per well. Next day the live
cells were incubated with 10 WM NH4Cl for 2 h.
LysoTracker Red (Molecular Probes, USA) dis-
solved to 100 nM in HEPES bu¡er, pH 7.5 including
10 WM NH4Cl was added to the cells for 20 min
before evaluation of pH in endocytic structures
[26]. The images of living cells were acquired by a
Zeiss LSM510 microscope equipped with a PlanNeo-
£uar 20/0.5 lens. Settings of the microscope were
unchanged throughout the experiments.
3. Results
3.1. Characterizations of HPV-16 E5 transfected cells
Three stable NIH3T3 A31 clones containing HPV-
16 E5 (E5 cells) were produced by transfection of the
cells with pJ46E5 constructs using lipofectin. Con-
Fig. 1. RT-PCR of NIH3T3 A31 cells transfected with HPV-16
E5 or the vector. c-DNA is ampli¢ed and separated on 1.5%
agarose gels. Lane M: The pBR*Hinf1 (pBR) size marker.
Lanes 1, 2, 3: Ampli¢cation of c-DNA from HPV-16 E5 trans-
fected cells, clone 1, clone 2 and clone 3. Lane P: The positive
control ampli¢ed from the reference RNA present in the kit,
and Lane N: Negative control, ampli¢cation of the c-DNA
from vector transfected cells. Basepairs (bp) are shown to the
left.
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trol cells were composed of three stable NIH3T3 A31
clones containing the expression vector alone.
The E5 transfected cells were tested for expression
of the E5 mRNA by reverse transcriptase PCR. The
three E5 transfected cell lines showed an ampli¢ed c-
DNA of 250 bp in agarose gels. This is the expected
size of the E5 transcript. Control cells were negative.
A reference RNA was included in the PCR kit as a
positive control (Fig. 1). The E5 cells were also char-
acterized by labeling of live cells with the pH sensi-
tive probe, LysoTracker Red. The control cells gave
a strong £uorescence when excitated at 543 nm
whereas the E5 cells gave a much weaker signal in-
dicating that pH in endocytic structures was less
Fig. 2. LysoTracker red staining of living cells. (a,c) Control NiH3T3 cells. (b,d) HPV-16 E5 transfected cells. (a) Control cells, clone
1. (c) Control cells, pooled clones. (b) HPV-16 E5 transfected cells, clone 1. (d) HPV-16 E5 transfected cells, pooled clones. (e,f) Con-
trol NiH3T3 cells, clone 1. (e) untreated and (f) cells treated with NH4Cl.
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Fig. 3. Windrose diagrams showing the migration of E5 transfected and control cells treated with 500 nM ba¢lomycin A1 3 h before
the recording of the experiment. Each windrose contains tracks of single cells from 10^15 di¡erent ¢elds from the same culture dish,
where the starting point of all tracks has been superimposed. Each track represents the motile behavior of a single cell recorded for
5 h with 15 min intervals. The circle in each frame marks the kGd2f of the recorded cells. The results shown are a representative ex-
periment from at least three independent experiments. Control (a, b), and E5 transfected cells (c, d) were incubated in DMEM con-
taining no additions (a, c) and 500 nM ba¢lomycin A1 (b, d).
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acidic. This is illustrated for clone 1 and for the pool
of cells (Fig. 2). Treatment of control cells with
NH4Cl also caused alkalinization of late endocytic
structures as shown by lysoTracker staining of clone
1 (Fig. 2).
3.2. E¡ect of E5 expression and ba¢lomycin A1
treatment on cell motility
Random cell motility of E5 transfected and con-
trol cells was estimated by use of time-lapse video
recording and image analysis. Pools of three control
cell lines and three E5 cell lines were used in all
experiments. The result from a representative experi-
ment is shown as windrose diagram in Fig. 3. Each
windrose shows the tracks of all cells from 10^12
microscopic ¢elds from a single experiment. The
starting points of all cell tracks have been superim-
posed. It can be seen that E5 expressing cells (Fig.
3c) on average showed a smaller displacement (the
reduced length of the tracks) when compared to con-
trol cells (Fig. 3a). This e¡ect was potentiated by
treatment with 500 nM ba¢lomycin A1 for 3 h
(Fig. 3b and d). The cell displacement was also ex-
pressed as the mean-square displacement, Gd2f, for
various d (time), using the methods of overlapping
intervals [21]. The motility of control cells and E5
transfected cells with and without ba¢lomycin A1
treatment is shown in a representative experiment
(Fig. 4). The motility of both control cells and E5
cells is reduced in the presence of ba¢lomycin A1.
The individual curves shown in Fig. 4 were used to
estimate the values of the root-mean-square speed, S,
the rate of di¡usion, R, and the time of persistence in
direction, P (Fig. 5). Since the motile behavior of
cultured cells is a persistent random walk [22],
changes in rate of di¡usion of cells, R, may re£ect
either changes in the root-mean-square speed, S, or
changes in the persistence time, P. It can be seen
from Fig. 5a that the expression of E5 inhibited the
rate of cell di¡usion, R, and strongly inhibited the
root-mean-square speed, S, whereas the persistence
time, P, was greatly elongated. This indicates that
E5 cells slow down and maintain their direction of
movement for longer time. Ba¢lomycin A1 also re-
duces R and S of both control and E5 cells (Fig. 5b,
Fig. 4. The mean-square displacement of E5 transfected and control cells treated with 500 nM ba¢lomycin A1. Data points are ex-
pressed as Gd2fþ S.E.M. based on cell number obtained by the method of overlapping intervals. Lines indicate curve-¢tting to the
equation Gd2f  2S2Pd3P13e3d=P. The result shown is a representative experiment from at least three independent experiments.
a, control cells ; b, E5 transfected cells ; R, control cells treated with 500 nM ba¢lomycin A1 ; D, E5 transfected cells treated with
500 nM ba¢lomycin A1.
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c). The P value is increased by the drug in control
cells and thus mimics the e¡ects of E5 (Fig. 5b). The
combined e¡ect of ba¢lomycin A1 and E5 however
leads to a strong reduction in P which means that the
cells change direction of motility with small time in-
tervals (Fig. 5c). Ba¢lomycin A1 also a¡ects cell dis-
placement (measured as rate of di¡usion) of control
cells and cells expressing E5 in a dose-dependent
manner (Fig. 6). A high concentration of ba¢lomycin
A1 (500 nM) caused a stronger decrease in cell mo-
tility of E5 expressing cells compared to control cul-
tures treated with the same concentration of the
drug. This high concentration can only be tolerated
by the cells for the short time treatment used in the
experiment (8 h) as described below.
3.3. Morphology of E5 transfected and
ba¢lomycin A1 treated cells
The e¡ect of the E5 expression on cellular mor-
phology was estimated by determination of cellular
area and form factor. All estimations were done on
cell pools to eliminate possible e¡ects of clonal var-
iation. The same e¡ects have been shown also for the
individual cell clones (data not shown). The morpho-
logical characterization was based on three independ-
ent experiments. On average the E5 expressing cells
exhibited a slightly enlarged area compared to con-
trol cells (Fig. 7a). The form factor was unchanged
(Fig. 7b). The e¡ect of ba¢lomycin A1 on cell mor-
phology was studied after treatment for 24 h with
two di¡erent concentrations of ba¢lomycin A1 :
25 nM and 100 nM. Ba¢lomycin A1 decreased the
area and increased the form factor of both control
and E5 transfected cells. The change was only signif-
icant after treatment with 100 nM ba¢lomycin A1
(Fig. 7).
However the motility studies were performed with
500 nM of ba¢lomycin A1 which inhibited the vac-
uolar ATPase s 80% [27,28], but this concentration
did not in£uence the morphological parameters dur-
ing the 8 h of treatment used for the motility experi-
ments (Fig. 8).
4. Discussion
The vacuolar H-ATPase is necessary for a proper
Fig. 5. Bar diagrams showing the estimated values of the root-
mean-square speed, S ; the rate of di¡usion, R ; the persistence
time, P. (a) E5 transfected and control cells, (b) control cells
and (c) E5 transfected cells treated with 500 nM ba¢lomycin
A1 (BF) based on the curve-¢tting shown in Fig. 3. Error bars
indicate the standard deviation of the estimates based on the
goodness of ¢t for curve-¢tting. (a): E, control cells ; o, E5
transfected cells ; (b, c) E, untreated cells ; F, cells treated with
500 nM ba¢lomycin A1 (BF).
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acidi¢cation of endocytic structures (for review see
[29]). It is also involved in the endocytotic process
and is speci¢cally inhibited by the drug ba¢lomycin
A1 [6,19,27,28]. It has been reported that the ba¢lo-
mycin A1 does not prevent endocytosis although the
transport process from early to late endosomes seems
impaired [30]. The vacuolar H-ATPase is also target
for the HPV-16 E5 oncoprotein which interacts with
the 16 kDa pore-forming subunit of the enzyme [11].
The E5 transfected cells also show an impaired acid-
i¢cation of endocytic structures [14], as shown in Fig.
2. This indicates that the vacuolar H-ATPase is
involved in cell transformation. Transfection of ker-
atinocytes with HPV-16 E5 leads to a delayed EGFR
degradation [15,18] and to a changed function of the
gap junctions [17]. The observation that ba¢lomycin
A1 prevents the regular degradation of EGF and
thus might in£uence the signalling pathway induced
by the mitogen is interesting and points to the in-
volvement of the vacuolar H-ATPase also in this
process [28]. Furthermore the e¡ect of ba¢lomycin
A1 is dependent on the cell type and is more pro-
nounced on cells transformed by tumor viruses [31].
We selected cell motility and cell morphology as
important biological end points for the analysis of
cells transfected with the E5 oncogene from HPV-
16 and cells where the vacuolar H-ATPase was in-
hibited by treatment with ba¢lomycin A1.
The motility evaluation clearly shows that both E5
protein expression and/or a 3 h treatment with ba¢-
lomycin A1 confer a reduced motility to cells. This
reduction is more pronounced after 8 h of treatment
(Figs. 3 and 4). The observed reduction of cell dif-
fusion of E5 transfected cells and of control cells
treated with ba¢lomycin A1 can be due to a reduced
speed although the persistence time is increased. The
strong inhibition of the motility of E5 transfected
cells in the presence of ba¢lomycin A1 demonstrates
that the E5 gene sensitizes cells to the drug and the
reduction correlates both to reduced cell speed and
decreased persistence time (Fig. 5). This indicates
that the mechanism leading to reduced cell motility
by E5 plus ba¢lomycin A1 is di¡erent from the
mechanism activated by either compound alone.
The mechanism leading to a changed motility is un-
known, but besides being related to cytoskeleton
changes it could result from a direct binding of the
E5 protein to the H-ATPase pore-forming subunits
Fig. 6. The e¡ect of treatment with 500 nM ba¢lomycin A1 on the rate of di¡usion, R. b, E5 transfected; a, control cells. The results
shown are a representative experiment from at least three independent experiments.
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of the pump thus making the enzyme more fragile
and sensible to the e¡ect of ba¢lomycin A1. Since cell
motility is known to require a constant recycling of
integrin receptors by means of endo- and exocytosis
[32,33] the integrity of the vacuolar H-ATPase
might also be of importance for the control of cell
locomotion by this pathway. Changes in cell motility
after ba¢lomycin A1 treatment did not correlate to
changes in cell morphology. This indicates that the
cells remained viable during the treatment. After 3 h
or 8 h of treatment with ba¢lomycin A1 which cor-
respond to the time of the motility experiments no
signi¢cant di¡erence in cell morphology was ob-
served (Fig. 8). A pronounced e¡ect on cell morphol-
ogy was only detected after 24 h treatment with ba-
¢lomycin A1 where a decrease in cell area and a
strong increase in form factor was obtained in both
control and E5 transfected cells.
The potentiated e¡ect of the E5 protein and ba¢-
lomycin A1 observed in the present study indicates
that the two components as mentioned above could
a¡ect di¡erent regions of the vacuolar proton pump,
or that more than one kind of ATPase is involved
[6]. Alternatively, ba¢lomycin A1 was reported re-
cently to induce p53 expression and apoptosis in
cardiac myocytes but not in cardiac ¢broblasts [34].
Whether ba¢lomycin A1 also induces apoptosis in
NIH3T3 cells is not known but if so, then the re-
duced motility could be a result of the death signals
being activated. However, at present the only target
known for the E5 protein and ba¢lomycin A1 is vac-
uolar H-ATPase and our data support the hypoth-
esis that the enzyme is necessary for normal cell lo-
comotion.
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Fig. 7. Cell morphology of control and E5 transfected cells
treated with ba¢lomycin A1 for 24 h. Cell area and form factor
is presented. Cells were incubated for 24 h at 37‡C in DMEM
followed by 24 h with ba¢lomycin A1. The number of cells var-
ied from 150 to 200 in the individual experiment. Results are
given as mean þ S.E.M. based on cell number. ***P6 0.001
when compared to control cells, using a two-sided Student test.
open columns, untreated cells ; hatched columns, 25 nM ba¢lo-
mycin A1 ; cross-hatched columns, 100 nM ba¢lomycin A1.
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